Day One Biopharmaceuticals

Filed a patent for "raf kinase inhibitors for treating tumors harboring gene fusions" on Thu, March 28, 2024

Filed a patent for "raf inhibitor for treating low grade glioma" on Thu, November 9, 2023

Filed a patent for "oral liquid suspension of pan-raf kinase inhibitor" on Thu, February 8, 2024

Filed a patent for "combination of raf inhibitor and mek inhibitor" on Thu, February 22, 2024

Filed a patent for "oral liquid suspension of pan-raf kinase inhibitor" on Mon, May 16, 2022

Filed a patent for "solid dispersion of pan-raf kinase inhibitor" on Thu, December 22, 2022